China’s NewCo Licensing Model Accelerates Global Biotech Collaboration
China’s biotech sector is making global headlines as a new wave of licensing deals reshapes how innovative drug candidates reach international markets. At the center of this trend is the NewCo licensing model, which has rapidly gained traction and positioned Chinese biotechs as key beneficiaries of cross-border pharmaceutical collaboration. Unlike traditional licensing agreements, where rights […]
China’s NewCo Licensing Model Accelerates Global Biotech Collaboration Read More »